BlueMar Capital Management’s Evolent Health EVH Stock Holding History

BlueMar Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-25,000	Closed	-$634K	–	69
2017 Q2	$634K	Sell	25,000 -25,837	-51%	-$621K	0.37%	63
2017 Q1	$1.13M	Buy	+50,837	New	+$976K	0.68%	50

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlueMar Capital Management's EVH Position: Q3 2017 in Review

BlueMar Capital Management sold out of Evolent Health (EVH) in Q3 2017, closing a stake of 25,000 shares — an estimated $634K sold.

BlueMar Capital Management first reported a position in EVH in Q1 2017 and held it in 2 quarters. The position peaked at $1.13M in Q1 2017. 166 funds tracked by Wall St. Rank hold EVH as of Q3 2017.

BlueMar Capital Management reported no remaining Evolent Health position as of Q3 2017 after selling out during the quarter.
BlueMar Capital Management sold 25,000 Evolent Health shares in Q3 2017, an estimated $634K.
BlueMar Capital Management first reported a position in Evolent Health in Q1 2017 and held it in 2 quarters.
BlueMar Capital Management's Evolent Health position peaked at $1.13M in Q1 2017.
166 funds tracked by Wall St. Rank held Evolent Health as of Q3 2017.

Based on BlueMar Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.